Johnson & Johnson: updates and filings

JNJNYSEHealthcare · Pharmaceutical Preparations

Price

$285.75

November 13, 2026Market cap $689B

DCF calculator

What Ploutos Investor adds for Johnson & Johnson

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 59 daysAround Jan 12, 2027 · for Q4 2026

last Oct 13, 2026next Jan 12, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

August 2026

July 2026

April 2026

February 2026

January 2026

October 2025

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 11, 2026 latest annualOct 21, 2026 latest quarterly
  • Oct 26, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Oct 21, 2026Quarterly reportfor the period to Sep 27, 2026
    Form10-Q
  • Oct 13, 2026Results of operations
    Form8-K
  • Aug 11, 2026Filing
    FormN-PX
  • Aug 6, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • Aug 4, 2026Officer or director change
    Form8-K
  • Jul 29, 2026Regulation FD disclosure
    Form8-K
  • Jul 28, 2026Regulation FD disclosure
    Form8-K
  • Jul 23, 2026Quarterly reportfor the period to Jun 28, 2026
    Form10-Q
  • Jul 15, 2026Results of operations
    Form8-K
  • Jun 25, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • Jun 25, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 27, 2026Conflict minerals report
    FormSD
  • May 13, 2026Its own holdings as an investment manager (13F)
    Form13F-HR
  • May 1, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 28, 2026Shareholder vote
    Form8-K
  • Apr 22, 2026Quarterly reportfor the period to Mar 29, 2026
    Form10-Q
  • Apr 14, 2026Results of operations, other material events
    Form8-K
  • Apr 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 18, 2026Its own holdings as an investment manager (13F) (amendment)
    Form13F-HR/A
  • Mar 18, 2026Its own holdings as an investment manager (13F) (amendment)
    Form13F-HR/A
  • Mar 11, 2026Annual report to shareholdersfor the period to Dec 28, 2025
    FormARS
  • Mar 11, 2026Additional annual meeting material
    FormDEFA14A
  • Mar 11, 2026Annual meeting proxy statement
    FormDEF 14A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Mar 10, 1994: every report, 8-K, meeting and letter. Of its other filings (1,317 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 97.

The full analysis

What do Johnson & Johnson's filings show?

The filings are where every one of Johnson & Johnson's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.